Viatris Stock Tumbles as Eyelid Inflammation Treatment Misses Target

• click to rate

  Posted by Two Blokes Jul 18 - Filed in Stock - 2 views
  
  The pharmaceutical company says its eye inflammation treatment didn't meet its target.